OPKO Health, Inc. (OPK) vs First Tracks Biotherapeutics Inc (TRAX)

A side-by-side comparison of OPKO Health, Inc. and First Tracks Biotherapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

OPK

OPKO Health, Inc.

$1.10B

$1.48HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

TRAX

First Tracks Biotherapeutics Inc

$1.12B

$32.04HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

Total return — OPK vs TRAX

growth of $100 · dividends reinvested · last 1y

OPK +37.7% (+37.7%/yr)TRAX +73.6% (+73.6%/yr)TRAX compounded faster over this window

OPK TRAX

OPK vs TRAX: by the numbers

•TRAX is the larger company ($1.12B vs $1.10B market cap).
•Both run net losses; TRAX's is the smaller (0.00% vs -12.40% net margin).

Metrics side by side

Valuation

Metric	OPK	TRAX
P/S ratio	1.88	N/A
P/B ratio	0.93	6.62

Profitability

Metric	OPK	TRAX
Gross margin	21.10%	0.00%
Operating margin	-36.08%	0.00%
Net margin	-12.40%	0.00%
ROE	-6.16%	-57.77%
ROIC	-8.86%	-59.76%

Growth (annualized)

Metric	OPK	TRAX
Revenue CAGR (5Y)	-21.00%	N/A
Total return CAGR (5Y)	-15.39%	N/A

Go deeper

Full OPK analysis Full TRAX analysis Interactive comparison tool

Dig into the metrics

OPKO Health ROE First Tracks Biotherapeutics ROE OPKO Health operating margin First Tracks Biotherapeutics operating margin OPKO Health revenue growth First Tracks Biotherapeutics revenue growth OPKO Health free cash flow First Tracks Biotherapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.